| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
| 05/09/2002 | US20020055466 Terpolymer of tyrosine, alanine and lysine randomly polymerized into a polypeptide |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055183 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 05/09/2002 | US20020055174 Complex for transferring an anionic substance of interest into a cell |
| 05/09/2002 | US20020055168 Streptococcus suis vaccines and diagnostic tests |
| 05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020055122 Administering to the recipient mammal for promoting acceptance of graft, an inhibitor of the CD40/ ligand- CD40 costimulatory interaction; introducing into the recipient mammal, hematopoietic stem cells and implanting the graft |
| 05/09/2002 | US20020054914 Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
| 05/09/2002 | US20020054902 Liposomes containing therapeutic genes are conjugated to targeting agents to provide transport of encapsulated gene across blood-retainal barrier and plasma membrane of ocular cell, where this gene expresses encoded therapeutical agent |
| 05/09/2002 | US20020054895 And at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectants |
| 05/09/2002 | US20020054888 Dissociated pili, their production and use |
| 05/09/2002 | US20020054887 Toxin has at least one amino acid change and is substantially non-lethal compared with wild type SPE-A toxin; for vaccines |
| 05/09/2002 | US20020054886 For treatment of disseminated candidiasis due to infection by C.albicans; monoclonal antibodies for use in passive immunization against candidal infections |
| 05/09/2002 | US20020054884 Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 05/09/2002 | US20020054883 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
| 05/09/2002 | US20020054882 Anti-human influenza virus antibody |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/09/2002 | US20020054879 Reacting protein with polysaccharide to produce mixture including protein-polysaccharide conjugate and free protein |
| 05/09/2002 | US20020054878 Anti-IgE antibodies |
| 05/09/2002 | US20020054877 Mammalian cytokine; related reagents |
| 05/09/2002 | US20020054873 Attenuating the tumor cells, introducing a nucleic acid molecule which encodes and OX-40 receptor binding agent which is expressed on the surface of tumor cells, administering the above preperation |
| 05/09/2002 | US20020054871 Treating a host suffering from hyperlipidemia resulting from elevated levels of at least one of very low density lipoproteins and triglycerides and effective amount of an agent that reduces the level of active apolipoprotein E |
| 05/09/2002 | US20020054870 A peptide containing atleast 6 amino acid residues, having 70% homology with part or all of the sequence containing specific 14 amino acids |
| 05/09/2002 | US20020054864 Generating a DNA fragment which expresses an antigenic protein or fragment; distributing on the particle surface to form particlulate polynucleotide, deliverying it to the cytoplasm of target cell to express antigenic protein |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203076A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 05/08/2002 | EP1203025A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND $g(b)1 INTEGRINS |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202745A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 05/08/2002 | EP1202741A1 Neurotropic virus transport |
| 05/08/2002 | EP1202700A1 Oil-in-water emulsion with improved stability |
| 05/08/2002 | EP1202630A1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0629240B1 Altered antibodies, products and processes relating thereto |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | DE10055703A1 Ex vivo blood lavage with oligomeric carbohydrates for removal of pathogens, hapten-containing antibody aggregates and amyloids, useful in treatment of e.g. multiple sclerosis and Alzheimer's disease |
| 05/08/2002 | DE10055702A1 Strictly autospecific antiserum production, for direct use as protective vaccine, by treating antiserum with aqueous polypeptide solution and treating suspension of obtained agglomerate with gamma-globulin |
| 05/08/2002 | DE10055698A1 Inhibiting allergic or atopic reactions, e.g. asthma, hay fever or eczema, by increasing serum levels of unbound gamma-globulin |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348332A Vaccines and gene therapy compositions and methods of making and using the same |
| 05/08/2002 | CN1347735A Polyepitope hepatitis C antigen complex polypeptide vaccine and its prepn and application |
| 05/08/2002 | CN1347734A Method for treating thrombosis diseases |
| 05/07/2002 | US6384206 Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
| 05/07/2002 | US6384190 Peptide of defined amino acid sequence which binds to human leukocyte antigen-a2 |
| 05/07/2002 | US6384018 For inducing immune responses in a vertebrate against mycobacterial epitopes |
| 05/07/2002 | US6383806 Method for the development of an HIV vaccine |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383774 Nucleotide sequences; nematocides; parasiticides; recombinant culture production of enzyme; veterinary medicine |
| 05/07/2002 | US6383765 Polypeptides of feline T-cell lymphotropic lentivirus |
| 05/07/2002 | US6383760 Contacting receptor with test compound, then determining if compound binds to receptor |
| 05/07/2002 | US6383741 Administering an attenuation virus |
| 05/07/2002 | US6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
| 05/07/2002 | US6383733 Methods of screening for pharmacologically active compounds for the treatment of tumour diseases |
| 05/07/2002 | US6383512 For delivering to cell a composition comprising local anesthetic and nucleic acid molecules that comprise a nucleotide sequence that encodes an antisense oligonucleotide, a ribozyme, and a triplex forming nucleic acid |
| 05/07/2002 | US6383498 Neuraminidase and galactose oxidase as vaccine adjuvant |
| 05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
| 05/07/2002 | US6383494 Heat shock proteins |
| 05/07/2002 | US6383493 Methods and compositions for eliciting an immune response with hsp70-peptide complexes |
| 05/07/2002 | US6383492 Treatment of infectious diseases with gp96-peptide complexes |
| 05/07/2002 | US6383491 Prevention of infectious diseases with hsp90-peptide complexes |
| 05/07/2002 | US6383488 Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | US6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | CA2223700C In ovo vaccination against coccidiosis |
| 05/07/2002 | CA2214503C Method for treating tumors |
| 05/07/2002 | CA2190494C Heterodimer polypeptide immunogen carrier composition and method |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/06/2002 | WO2002038178A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/06/2002 | CA2429404A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/02/2002 | WO2002035242A1 Method for identifying novel molecules binding with lox receptor |
| 05/02/2002 | WO2002035240A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034933A2 Methods and compositions for modifying biologically active target molecules |
| 05/02/2002 | WO2002034918A2 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
| 05/02/2002 | WO2002034893A2 Synthetic viruses and uses thereof |